UPDATE: Stifel Starts ProQR Therapeutics N.V. (PRQR) at Buy, $20 PT
Tweet Send to a Friend
(Updated - May 3, 2021 6:44 AM EDT)
Stifel analyst Dae Gon Ha initiates coverage on ProQR Therapeutics N.V ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Dae Gon Ha initiates coverage on ProQR Therapeutics N.V ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
